Search for: "State v. Bristol-Myers Squibb Company " Results 101 - 120 of 159
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2013, 2:24 am
 Unfortunately,without any thumbs, he was unable to forwardthem to the true recipient, Bristol-Myers Squibb When the parties engaged in correspondence, Teva refused to divulge its launch plans as it considered these plans confidential. [read post]
6 Jun 2013, 5:00 am by Bexis
Bristol-Myers Squibb Co., No. 12 Civ. 2238 (JPO), slip op. [read post]
5 Jun 2013, 5:29 am by Schachtman
Bristol-Myers Squibb, 97 F. [read post]
24 Jan 2013, 11:49 am by Bexis
Bristol-Myers Squibb Co., No. 06-6050 (FLW) (D.N.J. [read post]
15 Oct 2012, 1:24 am by Kevin LaCroix
It is not even the largest securities suit settlement, having been exceeded, among others, by Bristol Myers Squibb’s $300 million securities lawsuit settlement (about which refer here). [read post]
22 Aug 2012, 7:51 am by arester
Bristol-Myers Squibb Co., resulting in $515 million settlement arising from unlawful conduct including off-label promotion to induce government purchases of the antipsychotic drug Abilify; and United States ex rel. [read post]
1 Jul 2012, 2:54 am
T 0134/10 A patent in the name of Colgate-Palmolive Company relating to pearlised cleansing compositions was opposed by The Procter & Gamble Company and Sasol Germany GmbH. [read post]
18 Jun 2012, 1:38 pm
In the back of the Court’s mind, of course, was January’s $99 million settlement by Novartis for overtime claims by its pharmaceutical sales representatives following the Second Circuit’s 2010 decision in In re Novartis Wage & Hour Litig., and similar pending cases against Johnson & Johnson, Merck Co. and Bristol-Myers Squibb. [read post]
24 May 2012, 4:23 am by Max Kennerly, Esq.
Bristol-Myers Squibb Co., 2011 WL 2784101, at *3 (D.N.J. 2011), the Court did not hold that the warning label was enough to give notice. [read post]
20 May 2012, 1:11 pm
  The number 50 million:  The number of people in the US since 1997, that have taken Bristol-Myers Squibb's blood-thinning drug Plavix. [read post]